Breast Cancer Tumor Microenvironment and Molecular Aberrations Hijack Tumoricidal Immunity

Area of Science:

• Oncology
• Immunology
• Cancer Biology

Background:

• Breast cancer is a prevalent female malignancy with diverse subtypes and molecular heterogeneity.
• Tumor initiation involves genetic alterations, but immune evasion in the tumor microenvironment significantly impacts progression.
• Current treatments face limitations due to resistance and metastasis, with high fatality rates in advanced stages.

Purpose of the Study:

• To review the immune evasion strategies employed by breast cancer.
• To identify obstacles to effective anti-tumor immunotherapy.
• To discuss innovative therapeutic approaches for reinstating anti-tumor immunity.

Main Methods:

• Literature review of recent studies on breast cancer immunology and immunotherapy.
• Analysis of molecular and clinical data regarding immune evasion mechanisms.
• Identification of potential therapeutic targets and strategies.

Main Results:

• Breast tumors express neoantigens but often induce immune tolerance and suppression.
• Immune evasion involves down-regulation of antigen presentation, lack of effector cells, and accumulation of suppressive cells.
• Altered metabolism and hypoxia contribute to a permissive tumor microenvironment.

Conclusions:

• Tumor-induced immune suppression is a major hurdle for immunotherapy.
• Understanding immune evasion mechanisms is crucial for developing effective treatments.
• Innovative immunotherapies hold promise for eradicating metastatic breast cancer.